(MedPage Today) — Nirmatrelvir-ritonavir (Paxlovid) wasn’t any more effective at relieving long COVID symptoms than placebo, according to a large double-blind phase II trial.
At 90 days in RECOVER-VITAL, symptoms meaningfully improved among the…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
